NimBio

Developer of a non-invasive Inflammometer™ for early detection of flares in chronic inflammatory diseases.

Health Tech & Life Sciences
Active
Pre-Seed Tel Mond, Israel Founded 2019
Website ↗ LinkedIn
Last updated 2026-07-26
Total raised
$1.4M
Last: Undisclosed Round 2025-01
Stage
Pre-Seed
Founded
2019
Headcount
5
HQ
Tel Mond, Israel
Sector
Health Tech & Life Sciences

About

NimBio is an Israeli startup developing a non-invasive Inflammometer™ technology that can be integrated into everyday devices like smartwatches or fitness bands. The AI-powered solution aims to detect early signs of inflammation in real-time before a flare begins in chronic inflammatory diseases, reducing hospitalizations and complications through timely treatment optimization. NimBio's solution provides patients with a non-invasive wearable device that provides continuous measurements of inflammatory biomarkers, and accordingly improves IMIDs care.

Funding history · 3 rounds · $1.4M total

2024-12
A Round $500K
★ eHealth Ventures
2022-10
Seed Extension $870K
★ eHealth Ventures
2019-08
Seed Undisclosed
★ eHealth Ventures★ Israel Innovation Authority

Headcount over time

From 2 (2023-02) to 3 (2026-07) · +1 (+50%) · 8 points · source: Finder history + radar grounding
70 2023-02 2026-07

Q&A

What is NimBio's primary focus?
NimBio develops a non-invasive Inflammometer™ technology for the early detection of flares in chronic inflammatory diseases, aiming to integrate it into everyday devices like smartwatches.
When was NimBio founded?
NimBio was founded in January 2019.
What is NimBio's current employee count?
NimBio currently has 1-10 employees.
How much total funding has NimBio raised to date?
NimBio has raised a total of $2,000,000 USD.
When did NimBio complete its most recent funding round?
In January 2025, NimBio completed a Pre-Seed funding round, with eHealth Ventures as a lead investor.
Which investors participated in NimBio's Seed round in September 2019?
NimBio's Seed funding round in September 2019 included Israel Innovation Authority and eHealth Ventures as lead investors.
What was the amount raised in NimBio's Pre-Seed round in November 2022?
In November 2022, NimBio raised $870,000 USD in a Pre-Seed round, with eHealth Ventures as a lead investor.
Who are the founders of NimBio?
The founders of NimBio are Tal Atarot, who serves as Chief Executive Officer, and Yehuda Chowers, who is the Chief Medical Officer.
What is the product stage of NimBio's technology?
NimBio's product is currently in the clinical trial stage.

Team · 2

Yehuda Chowers
Founder · Chief Medical Officer
Tal Atarot
Founder · Chief Executive Officer

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical Decision Support
Technologies
SensingArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B2C

Highlights

Verified

Tags

wearablenon-invasiveearly-detectioninflammatory-diseaseschronic-diseasedigital-healthcaredecision-supportremote-monitoringwearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitenimbio.ai
LinkedInlinkedin.com/company/83554003

Identifiers & details

Founded2019-1
Employees (exact)5

Radar intelligence

Patents

EPO3

Web history (Wayback)

Domainnimbio.ai

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515919009
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2018-10-29
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events6 — shares_capital (3), people (2), other (1)
Registered addressהצבעוני 1 תל מונד

Recent registry events

DateEvent
2025-12-28הקצאת מניות
2025-12-28העברת מניות
2026-02-23עדכון דירקטורים-הוספת דירקטור
2025-12-22שינוי בתקנון
2025-12-22שינוי בהרכב הון - מניות-פיצול מניה
2026-02-05עדכון דירקטורים-הסרת דירקטור